Free Trial
$100 Off. Every Year. Lock In MarketBeat All Access at $149
Claim the Rate Lock
Claim MarketBeat All Access Sale Promotion

ResMed (RMD) Earnings Date, Estimates & Call Transcripts

ResMed logo
$253.43 +0.57 (+0.22%)
Closing price 10/26/2026 03:59 PM Eastern
Extended Trading
$253.12 -0.30 (-0.12%)
As of 05:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

ResMed Earnings Summary

ResMed released Q4 2026 earnings on August 6, 2026, reporting an EPS of $2.95, which topped the consensus estimate of $2.89 by $0.06. Quarterly revenue rose 8.6% year-over-year to $1.46 billion, above the consensus estimate of $1.46 billion. With a trailing EPS of $10.43 and a P/E Ratio of 22.64, ResMed's earnings are expected to grow 8.92% next year, from $12.11 to $13.19 per share.

Upcoming Q1
Earnings Date
Oct. 29After Market ClosesEstimated
Consensus EPS
(Aug. 6)
$2.89
Actual EPS
(Aug. 6)
$2.95 Beat By $0.06
Actual Revenue
(Aug. 6)
$1.46B

Q4 2026 Earnings Resources

RMD Upcoming Earnings

ResMed's Q1 2027 earnings is estimated for Thursday, October 29, 2026, based on past reporting schedules, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Q1 2027 Earnings Report

Slide Deck

ResMed's Q4 2026 Slide DeckFull Screen Slide Deck
Powered by Quartr
Get ResMed Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ResMed and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

RMD Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RMD Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

ResMed Upcoming Earnings Consensus

Report Date
October 29, 2026
Consensus EPS Estimate
$2.69
Consensus Revenue Estimate
$1.39B

ResMed Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20262$2.45$2.47$2.46
Q2 20262$2.66$2.66$2.66
Q3 20262$2.69$2.74$2.72
Q4 20262$2.71$2.84$2.78
FY 20268$10.51$10.71$10.61
Q1 20272$2.63$2.84$2.74
Q2 20272$2.73$2.93$2.83
Q3 20272$2.83$3.04$2.94
Q4 20271$3.01$3.01$3.01
FY 20277$11.20$11.82$11.51
Q1 20281$3.11$3.11$3.11
Q2 20281$3.14$3.14$3.14

ResMed Earnings History by Quarter

Report Date
0 Results
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
10/29/2026
(Estimated)		-$2.69---$1.39B-
8/6/2026Q4 2026$2.89$2.95+$0.06$2.64$1.46B$1.46B
4/30/2026Q3 2026$2.79$2.86+$0.07$2.74$1.42B$1.43B
1/30/2026Q2 2026$2.68$2.81+$0.13$2.68$1.40B$1.42B
10/31/2025Q1 2026$2.49$2.55+$0.06$2.37$1.33B$1.34B
7/31/2025Q4 2025$2.47$2.55+$0.08$2.58$1.33B$1.35B
4/23/2025Q3 2025$2.36$2.37+$0.01$2.48$1.28B$1.29B
1/30/2025Q2 2025$2.29$2.43+$0.14$2.34$1.27B$1.28B

ResMed Earnings - Frequently Asked Questions

ResMed has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 29th, 2026 based off last year's report dates. Learn more on RMD's earnings history.

In the previous quarter, ResMed (NYSE:RMD) reported $2.95 earnings per share (EPS) to beat the analysts' consensus estimate of $2.89 by $0.06. Learn more on analysts' earnings estimate vs. RMD's actual earnings.

The conference call for ResMed's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for ResMed's latest earnings report can be read online.
Read Transcript

ResMed's earnings report can be found in their filing with the SEC.
View SEC filing

ResMed (NYSE:RMD) has a recorded annual revenue of $5.65 billion.

ResMed (NYSE:RMD) has a recorded net income of $1.52 billion. RMD has generated $10.43 earnings per share over the last four quarters.

ResMed (NYSE:RMD) has a trailing price-to-earnings ratio of 22.64 and a forward price-to-earnings ratio of 20.93. The price/earnings-to-growth ratio is 1.55.

ResMed's earnings are expected to grow from $12.11 per share to $13.19 per share in the next year, which is a 8.92% increase.

Related Companies
Earnings Tools

Earnings data for NYSE:RMD is sourced from Fiscal.ai, with the most recent quarter reported on 8/6/2026. New results are added as companies report their earnings.
From Our Partners
80 Days Until America's Rare Earth Supply Chain Shift
China controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports t...
The Tomorrow Investor | Sponsoredtc pixel
Two charts tell you the future…
Gold miners are posting record cash flows, outperforming every other sector, yet mining still makes up just 1%...
Golden Portfolio | Sponsoredtc pixel
Would Anthropic IPO Burst the Bubble?
The biggest IPO in history is likely just weeks away… Anthropic, the company behind Claude AI, is rumoured ...
Crypto 101 Media | Sponsoredtc pixel
The investigation Porter spent tens of thousands to document
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...
Porter & Company | Sponsoredtc pixel
He turned $12K into $1.65M without touching Apple or Tesla
Tim Sykes turned $12,415 in gift money into more than $1.65 million before graduating college, without trading...
Tim Sykes | Sponsoredtc pixel
Last call for your free 0DTE report
The 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...
Profits Run | Sponsoredtc pixel
Why Gerardo Del Real says wait before buying uranium stocks
Gerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...
Digest Publishing | Sponsoredtc pixel
Elon Musk’s Hushed FCC Filing. Dec 8th.
Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the lar...
Paradigm Press | Sponsoredtc pixel